Steinman Michael A, Komaiko Kiya D R, Fung Kathy Z, Ritchie Christine S
Division of Geriatrics, San Francisco VA Medical Center, University of California, San Francisco, California, USA.
Pain Med. 2015 Feb;16(2):319-27. doi: 10.1111/pme.12613. Epub 2014 Oct 28.
There has been concern over rising use of prescription opioids in young and middle-aged adults. Much less is known about opioid prescribing in older adults, for whom clinical recommendations and the balance of risks and benefits differ from younger adults. We evaluated changes in use of opioids and other analgesics in a national sample of clinic visits made by older adults between 1999 and 2010.
DESIGN, SETTING, AND SUBJECTS: Observational study of adults aged 65 and older from the 1999-2010 National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, serial cross-sectional surveys of outpatient visits in the United States.
Medication use was assessed at each study visit and included medications in use prior to the visit and medications newly prescribed at the visit. Results were adjusted for survey weights and design factors to provide nationally representative estimates.
Mean age was 75 ± 7 years, and 45% of visits occurred in primary care settings. Between 1999-2000 and 2009-2010, the percent of clinic visits at which an opioid was used rose from 4.1% to 9.0% (P < 0.001). Although use of all major opioid classes increased, the largest contributor to increased use was hydrocodone-containing combination opioids, which rose from 1.1% to 3.5% of visits over the study period (P < 0.001). Growth in opioid use was observed across a wide range of patient and clinic characteristics, including in visits for musculoskeletal problems (10.7% of visits in 1999-2000 to 17.0% in 2009-2010, P < 0.001) and in visits for other reasons (2.8% to 7.3%, P < 0.001).
Opioid use by older adults visiting clinics more than doubled between 1999 and 2010, and occurred across a wide range of patient characteristics and clinic settings.
年轻及中年成年人中处方阿片类药物的使用量不断增加,这引发了人们的关注。对于老年人的阿片类药物处方情况,我们了解得要少得多,而老年人的临床建议以及风险与益处的平衡与年轻人有所不同。我们评估了1999年至2010年间全国范围内老年人门诊就诊样本中阿片类药物及其他镇痛药使用情况的变化。
设计、地点与研究对象:对1999 - 2010年美国国家门诊医疗护理调查和国家医院门诊医疗护理调查中65岁及以上成年人进行观察性研究,这两项调查是美国门诊就诊情况的系列横断面调查。
在每次研究就诊时评估用药情况,包括就诊前正在使用的药物以及就诊时新开具的药物。对调查权重和设计因素进行了结果调整,以提供具有全国代表性的估计值。
平均年龄为75 ± 7岁,45%的就诊发生在初级保健机构。在1999 - 2000年至2009 - 2010年期间,使用阿片类药物的门诊就诊百分比从4.1%升至9.0%(P < 0.001)。尽管所有主要阿片类药物类别使用量均增加,但使用量增加的最大贡献者是含氢可酮的复方阿片类药物,在研究期间其就诊占比从1.1%升至3.5%(P < 0.001)。在广泛的患者和诊所特征中均观察到阿片类药物使用量的增长,包括因肌肉骨骼问题就诊(从1999 - 2000年的就诊占比10.7%增至2009 - 2010年的17.0%,P < 0.001)以及因其他原因就诊(从2.8%增至7.3%,P < 0.001)。
1999年至2010年间,到诊所就诊的老年人阿片类药物使用量增加了一倍多,且在广泛的患者特征和诊所环境中均有发生。